LGND

Ligand Pharma

• TipRanks·4d ago

  Ligand Pharmaceuticals Bets Big on Royalty Growth

• TipRanks·5d ago

  Ligand Pharma Advances XOMA Royalty Acquisition with Amendment

• PUBT·5d ago

  XOMA Royalty amends Ligand merger deal to add HoldCo as party

• PUBT·5d ago

  Ligand amends XOMA Royalty merger agreement to add new holding company entity

• TipRanks·05/14 10:11

  Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), NeuroPace (NPCE) and Avalo Therapeutics (AVTX)

• TipRanks·05/12 11:21

  RBC Capital Keeps Their Buy Rating on Ligand Pharma (LGND)

• TipRanks·05/12 11:21

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ligand Pharma (LGND), Pliant Therapeutics (PLRX) and Oculis Holding (OCS)

• TipRanks·05/12 00:44

  Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push

• Dow Jones·05/08 17:18

  Ligand Pharmaceuticals Price Target Raised to $262.00/Share From $252.00 by RBC Capital

• Dow Jones·05/08 17:18

  Ligand Pharmaceuticals Is Maintained at Outperform by RBC Capital

• Benzinga·05/08 17:09

  RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $262

• Dow Jones·05/07 19:03

  Ligand Pharmaceuticals Down Over 9%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk

• TipRanks·05/07 16:50

  Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Brookdale Senior Living (BKD)

• TipRanks·05/07 15:17

  Ligand reports Q1 adjusted EPS $1.63, consensus $1.80

• TipRanks·05/07 15:12

  Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21